{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:54:14Z","timestamp":1792662854902,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T00:00:00Z","timestamp":1372809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00702-013-1062-5","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T05:50:58Z","timestamp":1372744258000},"page":"1623-1630","source":"Crossref","is-referenced-by-count":46,"title":["Melanin affinity and its possible role in neurodegeneration"],"prefix":"10.1007","volume":"120","author":[{"given":"Oskar","family":"Karlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Gunnar","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,3]]},"reference":[{"issue":"1","key":"1062_CR1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-4347(01)00486-8","volume":"768","author":"AF Aubry","year":"2002","unstructured":"Aubry AF (2002) Applications of affinity chromatography to the study of drug-melanin binding interactions. J Chromatogr B Analyt Technol Biomed Life Sci 768(1):67\u201374","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"1062_CR2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1212\/01.WNL.0000078320.18564.9F","volume":"61","author":"SA Banack","year":"2003","unstructured":"Banack SA, Cox PA (2003) Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology 61(3):387\u2013389","journal-title":"Neurology"},{"issue":"6","key":"1062_CR3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0361-9230(83)90218-6","volume":"10","author":"H Barden","year":"1983","unstructured":"Barden H, Levine S (1983) Histochemical observations on rodent brain melanin. Brain Res Bull 10(6):847\u2013851","journal-title":"Brain Res Bull"},{"issue":"3","key":"1062_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archneurol.2010.1","volume":"67","author":"JM Bertoni","year":"2010","unstructured":"Bertoni JM, Arlette JP, Fernandez HH, Fitzer-Attas C, Frei K, Hassan MN, Isaacson SH, Lew MF, Molho E, Ondo WG, Phillips TJ, Singer C, Sutton JP, Wolf JE Jr (2010) Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Arch Neurol 67(3):347\u2013352","journal-title":"Arch Neurol"},{"issue":"5","key":"1062_CR5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/01.wnl.0000344257.59693.cf","volume":"72","author":"AR Borenstein","year":"2009","unstructured":"Borenstein AR, Mortimer JA, Schellenberg GD, Galasko D (2009) The ALS\/PDC syndrome of Guam and the cycad hypothesis. Neurology 72(5):473","journal-title":"Neurology"},{"issue":"5","key":"1062_CR6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/01.wnl.0000344257.59693.cf","volume":"72","author":"WG Bradley","year":"2009","unstructured":"Bradley WG, Banack SA, Cox PA (2009) The ALS\/PDC syndrome of Guam and the cycad hypothesis. Neurology 72(5):473\u2013474","journal-title":"Neurology"},{"issue":"1","key":"1062_CR7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0161-6420(93)31696-9","volume":"100","author":"RJ Campbell","year":"1993","unstructured":"Campbell RJ, Steele JC, Cox TA, Loerzel AJ, Belli M, Belli DD, Kurland LT (1993) Pathologic findings in the retinal pigment epitheliopathy associated with the amyotrophic lateral sclerosis\/parkinsonism-dementia complex of Guam. Ophthalmology 100(1):37\u201342","journal-title":"Ophthalmology"},{"issue":"9","key":"1062_CR8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1021\/tx0155303","volume":"14","author":"DJ Claffey","year":"2001","unstructured":"Claffey DJ, Ruth JA (2001) Amphetamine adducts of melanin intermediates demonstrated by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry. Chem Res Toxicol 14(9):1339\u20131344","journal-title":"Chem Res Toxicol"},{"issue":"5","key":"1062_CR9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10540-006-9028-6","volume":"26","author":"F Copped\u00e8","year":"2006","unstructured":"Copped\u00e8 F, Mancuso M, Siciliano G, Migliore L, Murri L (2006) Genes and the environment in neurodegeneration. Biosci Rep 26(5):341\u2013367","journal-title":"Biosci Rep"},{"issue":"12","key":"1062_CR10","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0161-6420(89)32656-X","volume":"96","author":"TA Cox","year":"1989","unstructured":"Cox TA, McDarby JV, Lavine L, Steele JC, Calne DB (1989) A retinopathy on Guam with high prevalence in Lytico-Bodig. Ophthalmology 96(12):1731\u20131735","journal-title":"Ophthalmology"},{"issue":"5","key":"1062_CR11","first-page":"474","volume":"72","author":"R Cruz-Aguado","year":"2009","unstructured":"Cruz-Aguado R, Shaw CA (2009) The ALS\/PDC syndrome of Guam and the cycad hypothesis. Neurology 72(5):474","journal-title":"Neurology"},{"issue":"4741","key":"1062_CR12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.3080808","volume":"231","author":"RJ D\u2019Amato","year":"1986","unstructured":"D\u2019Amato RJ, Lipman ZP, Snyder SH (1986) Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. Science 231(4741):987\u2013989","journal-title":"Science"},{"issue":"6120","key":"1062_CR13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/327324a0","volume":"327","author":"RJ D\u2019Amato","year":"1987","unstructured":"D\u2019Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH (1987) Evidence for neuromelanin involvement in MPTP-induced neurotoxicity. Nature 327(6120):324\u2013326","journal-title":"Nature"},{"issue":"6","key":"1062_CR14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/10915810290169873","volume":"21","author":"P Dayhaw-Barker","year":"2002","unstructured":"Dayhaw-Barker P (2002) Retinal pigment epithelium melanin and ocular toxicity. Int J Toxicol 21(6):451\u2013454","journal-title":"Int J Toxicol"},{"issue":"6","key":"1062_CR15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM Lau de","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535","journal-title":"Lancet Neurol"},{"issue":"3","key":"1062_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archotol.1975.00780320043010","volume":"101","author":"L Dencker","year":"1975","unstructured":"Dencker L, Lindquist NG (1975) Distribution of labeled chloroquine in the inner ear. Arch Otolaryngol 101(3):185\u2013188","journal-title":"Arch Otolaryngol"},{"issue":"2","key":"1062_CR17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0300-483X(75)90122-5","volume":"5","author":"L Dencker","year":"1975","unstructured":"Dencker L, Lindquist NG, Ullberg S (1975) Distribution of an 125I-labelled chloroquine analogue in a pregnant macaca monkey. Toxicology 5(2):255\u2013265","journal-title":"Toxicology"},{"issue":"3","key":"1062_CR18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0006-2952(03)00293-4","volume":"66","author":"KL Double","year":"2003","unstructured":"Double KL, Gerlach M, Schunemann V, Trautwein AX, Zecca L, Gallorini M, Youdim MB, Riederer P, Ben-Shachar D (2003) Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem Pharmacol 66(3):489\u2013494","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1062_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.expneurol.2009.03.002","volume":"217","author":"KL Double","year":"2009","unstructured":"Double KL, Rowe DB, Carew-Jones FM, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Riederer P, Gerlach M, Halliday GM (2009) Anti-melanin antibodies are increased in sera in Parkinson\u2019s disease. Exp Neurol 217(2):297\u2013301","journal-title":"Exp Neurol"},{"issue":"3","key":"1062_CR20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005072-196507000-00003","volume":"24","author":"P Duffy","year":"1965","unstructured":"Duffy P, Tennyson VM (1965) Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia Nigra and locus Caeruleus in Parkinson\u2019s Disease. J Neuropathol Exp Neurol 24(3):398\u2013414","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"1062_CR21","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1046\/j.1471-4159.2003.01923.x","volume":"86","author":"BA Faucheux","year":"2003","unstructured":"Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC (2003) Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson\u2019s disease. J Neurochem 86(5):1142\u20131148","journal-title":"J Neurochem"},{"issue":"3","key":"1062_CR22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.neurobiolaging.2005.02.015","volume":"27","author":"H Fedorow","year":"2006","unstructured":"Fedorow H, Halliday GM, Rickert CH, Gerlach M, Riederer P, Double KL (2006) Evidence for specific phases in the development of human neuromelanin. Neurobiol Aging 27(3):506\u2013512","journal-title":"Neurobiol Aging"},{"issue":"8","key":"1062_CR23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.18.8.817","volume":"18","author":"GM Fenichel","year":"1968","unstructured":"Fenichel GM, Bazelon M (1968) Studies on neuromelanin. II. Melanin in the brainstems of infants and children. Neurology 18(8):817\u2013820","journal-title":"Neurology"},{"issue":"16","key":"1062_CR24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1212\/WNL.0b013e3181bd13a1","volume":"73","author":"X Gao","year":"2009","unstructured":"Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A (2009) Family history of melanoma and Parkinson disease risk. Neurology 73(16):1286\u20131291","journal-title":"Neurology"},{"issue":"2","key":"1062_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-510X(83)90221-6","volume":"58","author":"P Gaspar","year":"1983","unstructured":"Gaspar P, Berger B, Gay M, Hamon M, Cesselin F, Vigny A, Javoy-Agid F, Agid Y (1983) Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon. Immunocytochemical localization and relationships. J Neurol Sci 58(2):247\u2013267","journal-title":"J Neurol Sci"},{"issue":"1","key":"1062_CR26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1471-4159.2005.03019.x","volume":"93","author":"E Greggio","year":"2005","unstructured":"Greggio E, Bergantino E, Carter D, Ahmad R, Costin GE, Hearing VJ, Clarimon J, Singleton A, Eerola J, Hellstrom O, Tienari PJ, Miller DW, Beilina A, Bubacco L, Cookson MR (2005) Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson\u2019s disease. J Neurochem 93(1):246\u2013256","journal-title":"J Neurochem"},{"issue":"Pt 11","key":"1062_CR27","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/brain\/awh584","volume":"128","author":"GM Halliday","year":"2005","unstructured":"Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL (2005) Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson\u2019s disease. Brain: J Neurol 128(Pt 11):2654\u20132664","journal-title":"Brain: J Neurol"},{"issue":"6","key":"1062_CR28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00702-006-0449-y","volume":"113","author":"GM Halliday","year":"2006","unstructured":"Halliday GM, Fedorow H, Rickert CH, Gerlach M, Riederer P, Double KL (2006) Evidence for specific phases in the development of human neuromelanin. J Neural Transm 113(6):721\u2013728","journal-title":"J Neural Transm"},{"issue":"4","key":"1062_CR29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1974.tb13079.x","volume":"91","author":"WH Harrison","year":"1974","unstructured":"Harrison WH, Gray RM, Solomon LM (1974) Incorporation of d-amphetamine into pigmented guinea-pig hair. Br J Dermatol 91(4):415\u2013418","journal-title":"Br J Dermatol"},{"issue":"3","key":"1062_CR30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.mehy.2008.10.011","volume":"72","author":"E Herrero Hernandez","year":"2009","unstructured":"Herrero Hernandez E (2009) Pigmentation genes link Parkinson\u2019s disease to melanoma, opening a window on both etiologies. Med Hypotheses 72(3):280\u2013284","journal-title":"Med Hypotheses"},{"issue":"2","key":"1062_CR31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0306-4522(93)90349-K","volume":"56","author":"MT Herrero","year":"1993","unstructured":"Herrero MT, Hirsch EC, Kastner A, Ruberg M, Luquin MR, Laguna J, Javoy-Agid F, Obeso JA, Agid Y (1993) Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 56(2):499\u2013511","journal-title":"Neuroscience"},{"issue":"6180","key":"1062_CR32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334(6180):345\u2013348","journal-title":"Nature"},{"issue":"3","key":"1062_CR33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-4159.2009.06011.x","volume":"109","author":"LZ Huang","year":"2009","unstructured":"Huang LZ, Parameswaran N, Bordia T, Michael McIntosh J, Quik M (2009) Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys. J Neurochem 109(3):826\u2013837","journal-title":"J Neurochem"},{"key":"1062_CR34","doi-asserted-by":"crossref","unstructured":"Ishikawa A, Takahashi H (1998) Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. J Neurol 245 Suppl 3 (11):4\u20139","DOI":"10.1007\/PL00007745"},{"issue":"3","key":"1062_CR35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1034\/j.1600-0749.2003.00037.x","volume":"16","author":"S Ito","year":"2003","unstructured":"Ito S (2003) A Chemist\u2019s View of Melanogenesis. Pigment Cell Res 16(3):230\u2013236","journal-title":"Pigment Cell Res"},{"issue":"3","key":"1062_CR36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1751-1097.2007.00238.x","volume":"84","author":"S Ito","year":"2008","unstructured":"Ito S, Wakamatsu K (2008) Chemistry of mixed melanogenesis\u2014pivotal roles of dopaquinone. Photochem Photobiol 84(3):582\u2013592","journal-title":"Photochem Photobiol"},{"key":"1062_CR37","first-page":"267","volume":"60","author":"KA Jellinger","year":"1993","unstructured":"Jellinger KA, Kienzl E, Rumpelmaier G, Paulus W, Riederer P, Stachelberger H, Youdim MB, Ben-Shachar D (1993) Iron and ferritin in substantia nigra in Parkinson\u2019s disease. Adv Neurol 60:267\u2013272","journal-title":"Adv Neurol"},{"issue":"1","key":"1062_CR38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2302\/kjm.44.9","volume":"44","author":"K Jimbow","year":"1995","unstructured":"Jimbow K (1995) Current update and trends in melanin pigmentation and melanin biology. Keio J Med 44(1):9\u201318","journal-title":"Keio J Med"},{"issue":"1","key":"1062_CR39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1755-148X.2008.00508.x","volume":"22","author":"O Karlsson","year":"2009","unstructured":"Karlsson O, Berg C, Brittebo EB, Lindquist NG (2009) Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells\u2013a possible link between Parkinson-dementia complex and pigmentary retinopathy. Pigment Cell Melanoma Res 22(1):120\u2013130","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"1062_CR40","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","volume":"59","author":"A Kastner","year":"1992","unstructured":"Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y (1992) Is the vulnerability of neurons in the substantia nigra of patients with Parkinson\u2019s disease related to their neuromelanin content? J Neurochem 59(3):1080\u20131089","journal-title":"J Neurochem"},{"issue":"2","key":"1062_CR41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10633-007-9105-6","volume":"116","author":"U Kellner","year":"2008","unstructured":"Kellner U, Kellner S, Weinitz S (2008) Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol 116(2):119\u2013127","journal-title":"Doc Ophthalmol"},{"key":"1062_CR42","first-page":"73","volume":"142","author":"M Kemali","year":"1985","unstructured":"Kemali M, Gioffre D (1985) Anatomical localisation of neuromelanin in the brains of the frog and tadpole. Ultrastructural comparison of neuromelanin with other melanins. J Anat 142:73\u201383","journal-title":"J Anat"},{"issue":"3","key":"1062_CR43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1254\/jjp.84.237","volume":"84","author":"Y Kitamura","year":"2000","unstructured":"Kitamura Y, Shimohama S, Akaike A, Taniguchi T (2000) The parkinsonian models: invertebrates to mammals. Jpn J Pharmacol 84(3):237\u2013243","journal-title":"Jpn J Pharmacol"},{"key":"1062_CR44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.ne.11.030188.000501","volume":"11","author":"IJ Kopin","year":"1988","unstructured":"Kopin IJ, Markey SP (1988) MPTP toxicity: implications for research in Parkinson\u2019s disease. Annu Rev Neurosci 11:81\u201396","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"1062_CR45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00702-012-0842-7","volume":"120","author":"E Koutsilieri","year":"2013","unstructured":"Koutsilieri E, Lutz MB, Scheller C (2013) Autoimmunity, dendritic cells and relevance for Parkinson\u2019s disease. J Neural Transm 120(1):75\u201381","journal-title":"J Neural Transm"},{"issue":"4587","key":"1062_CR46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979\u2013980","journal-title":"Science"},{"issue":"4","key":"1062_CR47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46(4):598\u2013605","journal-title":"Ann Neurol"},{"issue":"3","key":"1062_CR48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0749.1993.tb00591.x","volume":"6","author":"BS Larsson","year":"1993","unstructured":"Larsson BS (1993) Interaction between chemicals and melanin. Pigment Cell Res 6(3):127\u2013133","journal-title":"Pigment Cell Res"},{"issue":"7","key":"1062_CR49","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0006-2952(79)90326-5","volume":"28","author":"B Larsson","year":"1979","unstructured":"Larsson B, Tjalve H (1979) Studies on the mechanism of drug-binding to melanin. Biochem Pharmacol 28(7):1181\u20131187","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"1062_CR50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00702-011-0753-z","volume":"119","author":"J Li","year":"2012","unstructured":"Li J, Yang J, Zhao P, Li S, Zhang R, Zhang X, Liu D, Zhang B (2012) Neuromelanin enhances the toxicity of alpha-synuclein in SK-N-SH cells. J Neural Transm 119(6):685\u2013691","journal-title":"J Neural Transm"},{"issue":"1","key":"1062_CR51","first-page":"190","volume":"200","author":"NG Lindquist","year":"1972","unstructured":"Lindquist NG (1972) Accumulation in vitro of 35 S-chlorpromazine in the neuromelanin of human substantia nigra and locus coeruleus. Arch Int Pharmacodyn Ther 200(1):190\u2013195","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1062_CR52","first-page":"1","volume":"325","author":"NG Lindquist","year":"1973","unstructured":"Lindquist NG (1973) Accumulation of drugs on melanin. Acta Radiol Diagn (Stockh) 325:1\u201392","journal-title":"Acta Radiol Diagn (Stockh)"},{"issue":"Suppl 2","key":"1062_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0773.1972.tb03310.x","volume":"2","author":"NG Lindquist","year":"1972","unstructured":"Lindquist NG, Ullberg S (1972) The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography. Acta Pharmacologica et Toxicologica 2(Suppl 2):1\u201332","journal-title":"Acta Pharmacologica et Toxicologica"},{"issue":"2","key":"1062_CR54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0773.1986.tb00149.x","volume":"59","author":"NG Lindquist","year":"1986","unstructured":"Lindquist NG, Lyden-Sokolowski A, Larsson BS (1986) Accumulation of a parkinsonism-inducing neurotoxin in melanin-bearing neurons: autoradiographic studies on 3H-MPTP. Acta Pharmacologica et Toxicologica 59(2):161\u2013164","journal-title":"Acta Pharmacologica et Toxicologica"},{"issue":"3","key":"1062_CR55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0749.1987.tb00403.x","volume":"1","author":"NG Lindquist","year":"1987","unstructured":"Lindquist NG, Larsson BS, Lyden-Sokolowski A (1987) Neuromelanin and its possible protective and destructive properties. Pigment Cell Res 1(3):133\u2013136","journal-title":"Pigment Cell Res"},{"issue":"1","key":"1062_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(88)90002-X","volume":"93","author":"NG Lindquist","year":"1988","unstructured":"Lindquist NG, Larsson BS, Lyden-Sokolowski A (1988) Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin. Neurosci Lett 93(1):1\u20136","journal-title":"Neurosci Lett"},{"issue":"23","key":"1062_CR57","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e31821e554e","volume":"76","author":"R Liu","year":"2011","unstructured":"Liu R, Gao X, Lu Y, Chen H (2011) Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology 76(23):2002\u20132009","journal-title":"Neurology"},{"issue":"2","key":"1062_CR58","first-page":"230","volume":"259","author":"A Lyden","year":"1982","unstructured":"Lyden A, Larsson B, Lindquist NG (1982) Studies on the melanin affinity of haloperidol. Arch Int Pharmacodyn Ther 259(2):230\u2013243","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"5","key":"1062_CR59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-0773.1983.tb03446.x","volume":"53","author":"A Lyden","year":"1983","unstructured":"Lyden A, Bondesson U, Larsson BS, Lindquist NG (1983) Melanin affinity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, an inducer of chronic parkinsonism in humans. Acta Pharmacol Toxicol (Copenh) 53(5):429\u2013432","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"issue":"2","key":"1062_CR60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JAD-2003-5208","volume":"5","author":"QL Ma","year":"2003","unstructured":"Ma QL, Chan P, Yoshii M, Ueda K (2003) Alpha-synuclein aggregation and neurodegenerative diseases. J Alzheimer\u2019s Dis (JAD) 5(2):139\u2013148","journal-title":"J Alzheimer\u2019s Dis (JAD)"},{"issue":"4","key":"1062_CR61","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0749.1999.tb00760.x","volume":"12","author":"U Mars","year":"1999","unstructured":"Mars U, Larsson BS (1999) Pheomelanin as a binding site for drugs and chemicals. Pigment Cell Res 12(4):266\u2013274","journal-title":"Pigment Cell Res"},{"key":"1062_CR62","first-page":"256","volume":"95","author":"CD Marsden","year":"1961","unstructured":"Marsden CD (1961) Pigmentation in the nucleus substantiae nigrae of mammals. J Anat 95:256\u2013261","journal-title":"J Anat"},{"issue":"2","key":"1062_CR63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chroma.2010.11.015","volume":"1218","author":"MP Marszall","year":"2011","unstructured":"Marszall MP, Bucinski A, Gorynski K, Proszowska A, Kaliszan R (2011) Magnetic beads method for determination of binding of drugs to melanin. J Chromatogr A 1218(2):229\u2013236","journal-title":"J Chromatogr A"},{"issue":"4","key":"1062_CR64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cne.20036","volume":"471","author":"AL McCormack","year":"2004","unstructured":"McCormack AL, Di Monte DA, Delfani K, Irwin I, DeLanney LE, Langston WJ, Janson AM (2004) Aging of the nigrostriatal system in the squirrel monkey. J Comp Neurol 471(4):387\u2013395","journal-title":"J Comp Neurol"},{"key":"1062_CR65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2202-12-116","volume":"12","author":"U Oberlander","year":"2011","unstructured":"Oberlander U, Pletinckx K, Dohler A, Muller N, Lutz MB, Arzberger T, Riederer P, Gerlach M, Koutsilieri E, Scheller C (2011) Neuromelanin is an immune stimulator for dendritic cells in vitro. BMC Neurosci 12:116","journal-title":"BMC Neurosci"},{"issue":"2","key":"1062_CR66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00702-003-0080-0","volume":"111","author":"A Ostergren","year":"2004","unstructured":"Ostergren A, Annas A, Skog K, Lindquist NG, Brittebo EB (2004) Long-term retention of neurotoxic beta-carbolines in brain neuromelanin. J Neural Transm 111(2):141\u2013157","journal-title":"J Neural Transm"},{"issue":"6","key":"1062_CR67","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00008390-199712000-00006","volume":"7","author":"A Palumbo","year":"1997","unstructured":"Palumbo A, Mars U, De Martino L, d\u2019Ischia M, Napolitano A, Larsson BS, Prota G (1997) Selective incorporation of the prototype melanoma seeker thiourea into nascent melanin: a chemical insight. Melanoma Res 7(6):478\u2013485","journal-title":"Melanoma Res"},{"issue":"9","key":"1062_CR68","doi-asserted-by":"crossref","first-page":"e45183","DOI":"10.1371\/journal.pone.0045183","volume":"7","author":"T Pan","year":"2012","unstructured":"Pan T, Zhu J, Hwu WJ, Jankovic J (2012) The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS ONE 7(9):e45183","journal-title":"PLoS ONE"},{"issue":"5","key":"1062_CR69","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/WNL.58.5.765","volume":"58","author":"CC Plato","year":"2002","unstructured":"Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, Torres JM, Wiederholt W (2002) ALS and PDC of Guam. Neurology 58(5):765\u2013773","journal-title":"Neurology"},{"issue":"2","key":"1062_CR70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/aje\/kwf175","volume":"157","author":"CC Plato","year":"2003","unstructured":"Plato CC, Garruto RM, Galasko D, Craig U-K, Plato M, Gamst A, Torres JM, Wiederholt W (2003) Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60\u00a0years. Am J Epidemiol 157(2):149\u2013157","journal-title":"Am J Epidemiol"},{"issue":"5321","key":"1062_CR71","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"key":"1062_CR72","first-page":"522","volume":"1","author":"AM Potts","year":"1962","unstructured":"Potts AM (1962a) The concentration of phenothiazines in the eye of experimental animals. Invest Ophthalmol 1:522\u2013530","journal-title":"Invest Ophthalmol"},{"key":"1062_CR73","first-page":"517","volume":"60","author":"AM Potts","year":"1962","unstructured":"Potts AM (1962b) Uveal pigment and phenothiazine compounds. Trans Am Ophthalmol Soc 60:517\u2013552","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1062_CR74","first-page":"399","volume":"3","author":"AM Potts","year":"1964","unstructured":"Potts AM (1964a) Further studies concerning the accumulation of polycyclic compounds on uveal melanin. Invest Ophthalmol 3:399\u2013404","journal-title":"Invest Ophthalmol"},{"key":"1062_CR75","first-page":"405","volume":"3","author":"AM Potts","year":"1964","unstructured":"Potts AM (1964b) The reaction of uveal pigment in vitro with polycyclic compounds. Invest Ophthalmol 3:405\u2013416","journal-title":"Invest Ophthalmol"},{"key":"1062_CR76","volume-title":"Melanins and melanogenesis","author":"G Prota","year":"1992","unstructured":"Prota G (1992) Melanins and melanogenesis. Academic Press, Inc., San Diego"},{"issue":"4","key":"1062_CR77","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/oxfordjournals.aje.a112098","volume":"101","author":"DM Reed","year":"1975","unstructured":"Reed DM, Torres JM, Brody JA (1975) Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam 1945\u20131972. Am J Epidemiol 101(4):302\u2013310","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1062_CR78","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/oxfordjournals.aje.a114515","volume":"125","author":"D Reed","year":"1987","unstructured":"Reed D, Labarthe D, Chen KM, Stallones R (1987) A cohort study of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and Rota. Am J Epidemiol 125(1):92\u2013100","journal-title":"Am J Epidemiol"},{"issue":"10","key":"1062_CR79","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2967\/jnumed.109.066175","volume":"50","author":"G Ren","year":"2009","unstructured":"Ren G, Miao Z, Liu H, Jiang L, Limpa-Amara N, Mahmood A, Gambhir SS, Cheng Z (2009) Melanin-targeted preclinical PET imaging of melanoma metastasis. J Nucl Med 50(10):1692\u20131699","journal-title":"J Nucl Med"},{"key":"1062_CR80","volume-title":"Development of the nervous system, 2nd edn","year":"2006","unstructured":"Sanes DH, Reh TA, Harris WA (eds) (2006) Development of the nervous system, 2nd edn. Academic press Elsevier, Amsterdam"},{"issue":"3","key":"1062_CR81","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/1011-1344(92)85027-R","volume":"12","author":"T Sarna","year":"1992","unstructured":"Sarna T (1992) Properties and function of the ocular melanin\u2013a photobiophysical view. J Photochem Photobiol, B 12(3):215\u2013258","journal-title":"J Photochem Photobiol, B"},{"issue":"11","key":"1062_CR82","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","volume":"108","author":"N Schmidt","year":"2001","unstructured":"Schmidt N, Ferger B (2001) Neurochemical findings in the MPTP model of Parkinson\u2019s disease. J Neural Transm 108(11):1263\u20131282","journal-title":"J Neural Transm"},{"issue":"10\u201311","key":"1062_CR83","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00702-004-0211-2","volume":"111","author":"M Shamoto-Nagai","year":"2004","unstructured":"Shamoto-Nagai M, Maruyama W, Akao Y, Osawa T, Tribl F, Gerlach M, Zucca FA, Zecca L, Riederer P, Naoi M (2004) Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells. J Neural Transm 111(10\u201311):1253\u20131265","journal-title":"J Neural Transm"},{"issue":"5","key":"1062_CR84","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1755-148X.2009.00610.x","volume":"22","author":"JD Simon","year":"2009","unstructured":"Simon JD, Peles D, Wakamatsu K, Ito S (2009) Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function. Pigment Cell Melanoma Res 22(5):563\u2013579","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4814","key":"1062_CR85","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.3603037","volume":"237","author":"PS Spencer","year":"1987","unstructured":"Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, Robertson RC (1987) Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 237(4814):517\u2013522","journal-title":"Science"},{"issue":"5","key":"1062_CR86","first-page":"474","volume":"72","author":"PS Spencer","year":"2009","unstructured":"Spencer PS, Palmer V, Kisby G (2009) The ALS\/PDC syndrome of Guam and the cycad hypothesis. Neurology 72(5):474\u2013475","journal-title":"Neurology"},{"issue":"21","key":"1062_CR87","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.wnl.0000312571.81091.26","volume":"70","author":"JC Steele","year":"2008","unstructured":"Steele JC, McGeer PL (2008) The ALS\/PDC syndrome of Guam and the cycad hypothesis. Neurology 70(21):1984\u20131990","journal-title":"Neurology"},{"issue":"22","key":"1062_CR88","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","volume":"97","author":"D Sulzer","year":"2000","unstructured":"Sulzer D, Bogulavsky J, Larsen KE, Behr G, Karatekin E, Kleinman MH, Turro N, Krantz D, Edwards RH, Greene LA, Zecca L (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci USA 97(22):11869\u201311874","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1062_CR89","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.281.4.341","volume":"281","author":"CM Tanner","year":"1999","unstructured":"Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW (1999) Parkinson disease in twins: an etiologic study. JAMA 281(4):341\u2013346","journal-title":"JAMA"},{"issue":"9","key":"1062_CR90","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archneurol.2009.195","volume":"66","author":"CM Tanner","year":"2009","unstructured":"Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW (2009) Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol 66(9):1106\u20131113","journal-title":"Arch Neurol"},{"key":"1062_CR91","doi-asserted-by":"crossref","unstructured":"Thomas B, Beal MF (2007) Parkinson\u2019s disease. Hum Mol Genet 16 Spec No. 2:R183\u2013194","DOI":"10.1093\/hmg\/ddm159"},{"key":"1062_CR92","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-211-73574-9_8","volume":"72","author":"F Tribl","year":"2007","unstructured":"Tribl F, Arzberger T, Riederer P, Gerlach M (2007) Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis. J Neural Transm Suppl 72:51\u201355","journal-title":"J Neural Transm Suppl"},{"issue":"1","key":"1062_CR93","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10633-005-7349-6","volume":"110","author":"R Tzekov","year":"2005","unstructured":"Tzekov R (2005) Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol 110(1):111\u2013120","journal-title":"Doc Ophthalmol"},{"issue":"5264","key":"1062_CR94","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/2271257a0","volume":"227","author":"S Ullberg","year":"1970","unstructured":"Ullberg S, Lindquist NG, Sjostrand SE (1970) Accumulation of chorio-retinotoxic drugs in the foetal eye. Nature 227(5264):1257\u20131258","journal-title":"Nature"},{"issue":"4","key":"1062_CR95","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1471-4159.2003.01917.x","volume":"86","author":"K Wakamatsu","year":"2003","unstructured":"Wakamatsu K, Fujikawa K, Zucca FA, Zecca L, Ito S (2003) The structure of neuromelanin as studied by chemical degradative methods. J Neurochem 86(4):1015\u20131023","journal-title":"J Neurochem"},{"issue":"1","key":"1062_CR96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1755-148X.2007.00415.x","volume":"21","author":"K Wakamatsu","year":"2008","unstructured":"Wakamatsu K, Hu DN, McCormick SA, Ito S (2008) Characterization of melanin in human iridal and choroidal melanocytes from eyes with various colored irides. Pigment Cell Melanoma Res 21(1):97\u2013105","journal-title":"Pigment Cell Melanoma Res"},{"key":"1062_CR97","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02860136","volume":"17","author":"MG Whiting","year":"1963","unstructured":"Whiting MG (1963) Toxicity of cycads. Econ Bot 17:271\u2013302","journal-title":"Econ Bot"},{"issue":"3","key":"1062_CR98","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1096\/fj.02-0314fje","volume":"17","author":"H Wilms","year":"2003","unstructured":"Wilms H, Rosenstiel P, Sievers J, Deuschl G, Zecca L, Lucius R (2003) Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson\u2019s disease. Faseb J 17(3):500\u2013502","journal-title":"Faseb J"},{"issue":"12","key":"1062_CR99","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.neurobiolaging.2007.04.009","volume":"29","author":"K Wirdefeldt","year":"2008","unstructured":"Wirdefeldt K, Gatz M, Bakaysa SL, Fiske A, Flensburg M, Petzinger GM, Widner H, Lew MF, Welsh M, Pedersen NL (2008) Complete ascertainment of Parkinson disease in the Swedish Twin Registry. Neurobiol Aging 29(12):1765\u20131773","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1062_CR100","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00702-011-0636-3","volume":"118","author":"Q Xuan","year":"2011","unstructured":"Xuan Q, Xu SL, Lu DH, Yu S, Zhou M, Ueda K, Cui YQ, Zhang BY, Chan P (2011) Increased expression of alpha-synuclein in aged human brain associated with neuromelanin accumulation. J Neural Transm 118(11):1575\u20131583","journal-title":"J Neural Transm"},{"issue":"3","key":"1062_CR101","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","volume":"510","author":"L Zecca","year":"2002","unstructured":"Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson\u2019s disease. FEBS Lett 510(3):216\u2013220","journal-title":"FEBS Lett"},{"issue":"11","key":"1062_CR102","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tins.2003.08.009","volume":"26","author":"L Zecca","year":"2003","unstructured":"Zecca L, Zucca FA, Wilms H, Sulzer D (2003) Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci 26(11):578\u2013580","journal-title":"Trends Neurosci"},{"issue":"1","key":"1062_CR103","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00401-008-0361-7","volume":"116","author":"L Zecca","year":"2008","unstructured":"Zecca L, Wilms H, Geick S, Claasen J-H, Brandenburg L-O, Holzknecht C, Panizza M, Zucca F, Deuschl G, Sievers J, Lucius R (2008) Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson\u2019s disease. Acta Neuropathol 116(1):47\u201355","journal-title":"Acta Neuropathol"},{"key":"1062_CR104","doi-asserted-by":"crossref","unstructured":"Zhang W, Phillips K, Wielgus A, Liu J, Albertini A, Zucca F, Faust R, Qian S, Miller D, Chignell C, Wilson B, Jackson-Lewis V, Przedborski S, Joset D, Loike J, Hong J-S, Sulzer D, Zecca L (2011) Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease. Neurotox Res 19(1):63\u201372","DOI":"10.1007\/s12640-009-9140-z"},{"key":"1062_CR105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/E591","volume":"5","author":"W Zhang","year":"2013","unstructured":"Zhang W, Zecca L, Wilson B, Ren HW, Wang YJ, Wang XM, Hong JS (2013) Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death. Front Biosci (Elite Ed) 5:1\u201311","journal-title":"Front Biosci (Elite Ed)"},{"issue":"1\u20132","key":"1062_CR106","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(01)03292-9","volume":"926","author":"W Zhou","year":"2002","unstructured":"Zhou W, Schaack J, Zawada WM, Freed CR (2002) Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture. Brain Res 926(1\u20132):42\u201350","journal-title":"Brain Res"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-013-1062-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1062-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T16:00:55Z","timestamp":1715616055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-013-1062-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,3]]},"references-count":106,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1007\/s00702-013-1062-5","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,3]]}}}